Baron23
Well-Known Member
im thinking a nice country pub lunch somewhere to meet..
We will be there!! hahaha
Sponsored by |
---|
im thinking a nice country pub lunch somewhere to meet..
An expert panel of clinicians set up to advise ministers on medicinal cannabis licence applications has started accepting applications.
Published 27 June 2018
From:
Home Office
From today (27 June) an expert panel will begin accepting applications from senior clinicians to prescribe cannabis-based medicines.
Announced in Parliament last week by the Policing Minister, the panel will be led by the Chief Medical Officer for Northern Ireland, Dr Michael McBride.
The panel, who will meet for the first time this week, will assess individual applications for the prescription of cannabis-based products based upon set criteria to ensure the treatment is safe. These applications must be made by senior clinicians who are on the General Medical Council’s register with an active licence to practice.
The process has been designed to be swift and accessible. Once the panel has made its recommendation to ministers, it will be for the Home Office or the Department of Health in Northern Ireland to determine whether to issue a licence and any application can expect to receive a final decision within 2 to 4 weeks.
The government is also committed to reviewing the fees paid for licences that are awarded as a result of the advice of the expert panel.
Policing Minister Nick Hurd said:
I completely sympathise with the families who have been facing desperate situations to find treatment and we have taken action, creating an expert panel to review individual medicinal cannabis licence applications.
Clinicians must be at the heart of the process to provide the reassurance that prescribing unlicensed and potentially untested products is in the best interests of the patient.
I look forward to receiving the expert panel’s recommendations in the knowledge that these families will be prescribed the most appropriate course of treatment, firmly based on medical evidence. We have been clear that we will continue to push hard against any unnecessary bureaucracy in the system.
Chief Medical Officer for Northern Ireland Dr Michael McBride said:
The establishment of this panel means that applications from patients’ doctors to prescribe, supply and provide access to cannabis-related medicines can now be considered and endorsed on the basis of best clinical practice in order to ensure safe and appropriate care for patients.
The government also committed today to urgently reviewing the fees paid for licences that are awarded as a result of the advice of the expert panel. In the meantime, for applications for a licence made by the NHS, neither individual patients nor their families will be asked to make any financial contribution towards the cost of any licence that may be issued.
Last week the Home Secretary also announced a 2-part review looking at the scheduling of cannabis, which will be carried out by Chief Medical Officer Professor Dame Sally Davies and the Advisory Council for the Misuse of Drugs. The expert panel is an interim measure while the review is ongoing.
The Home Secretary received part one of the review today [27 June] and will commission part 2 from the ACMD within the next few days. If this review identifies significant medicinal and therapeutic benefits, then the intention would be to reschedule medicinal cannabis and related products for therapeutic use.
Notes about the application process:
Clinical applications can be made on GOV.UK.
Applications must be made by senior clinicians who are on the General Medical Council’s relevant specialist register with an active licence to practice.
The panel will assess applications against several criteria. They are:
- whether there is evidence from a patient’s own case that they have benefited from a cannabis-based medicine, or
- whether there is evidence from existing clinical trials which indicate that a patient will benefit from a cannabis-based medicine, or
- whether the clinician considers there is an otherwise unmet special clinical need that could be addressed through use of a cannabis-based medicine by the patient
We will be there!! hahaha
Its happening.. its actually happening...
This is brilliant news... not for rec stoners, but for families in desperate need to help their children...
Can one consume CANNABIS in FRANCE?
ENGLAND @Kellya86 will help me!
I will get some CBD oil to hold me over?I would not recommend trying to buy cannabis in France. You're better off, much better off traveling with edibles or some type of canna pill mixed in with prescribed meds. If in a private home and offered a smoke I would say that's good, go for it.
In my experience in 'most' of Europe hash is the order of the day. Most of the weed is just that. Weed. African grown mountain/bush weed that tastes like dried lawn clippings. Not worth the headache.That's not to say you can't get good stuffs in Europe, but it helps if you know someone. One thing, is traveling by train can be good. Especially if visiting Amsterdam about a 3 and a half hour ride to Paris.
Wishing you safe travels.
The Home Office’s recent promise to review policy on the medical use of cannabis has, as promised, been turned around quickly. Carried out by Professor Dame Sally Davies, it predictably brings good news and bad for patients who rely on cannabis for medicinal purposes.
The main takeaway from this “review of contemporary reviews” is the recommendation that the “whole class of cannabis based medicinal products be moved out of Schedule 1”.
This represents a limited but significant victory. Drugs in Schedule 1 are considered to have little or no therapeutic value and are therefore not available to be prescribed or held legally with a prescription. It is likely that cannabis based medicinal products will therefore be recategorised into Schedule 2, 3, 4 or 5, which make it legal to possess a drug with a valid prescription from a registered medical practitioner. Sativex, which uses a specific extract of cannabis and is prescribed for spasticity in MS, is currently controlled under Schedule 4.
However, the Dame’s review “does not consider the use of medicinal cannabis products for non-medicinal or recreational purposes, or where those wishing to provide cannabis based medicinal products are not registered medical practitioners”. It therefore does not address the right to grow.
In fact it rules the prospect out:
“Cannabis has many active chemicals and only cannabis or derivatives produced for medical use can be assumed to have the correct concentrations and ratios. Using other forms, such as grown or street cannabis, as medicine for therapeutic benefit is potentially dangerous. The evidence that cannabis and some of its derivatives can be addictive and harmful has been known for some time and is not disputed by recent science, so I believe the reasons it is a controlled drug in the UK stand.
“Because different forms of grown cannabis have different concentrations and ratios of THC, grown or street cannabis cannot safely be substituted for medicinal cannabis.”
Denying the right to grow obviously shows distrust in patients’ ability to self-medicate, and denies them the ability to medicate at a low cost.
However, back on the positive side of things, the report recognises that
“there is now conclusive evidence of the therapeutic benefit of cannabis based medicinal products for certain medical conditions and reasonable evidence of therapeutic benefit in several other medical conditions. This evidence has been reviewed in whole or part, and considered robust, by some of the leading international scientific and regulatory bodies, as well as the World Health Organization (WHO). As Schedule 1 drugs by definition have little or no therapeutic potential, it is therefore now clear that from a scientific point of view keeping cannabis based medicinal products in Schedule 1 is very difficult to defend. Moreover, I believe that it would not make sense to move cannabis and its derivatives out of Schedule 1 whilst leaving synthetic cannabinoids, which the evidence suggests have potentially greater therapeutic benefit and less potential for harm, in Schedule 1. I therefore recommend that the whole class of cannabis based medicinal products be moved out of Schedule 1.
“Moving these drugs out of Schedule 1 would allow them to be prescribed under controlled conditions by registered practitioners for medical benefit. In addition, moving the whole class of cannabis based medicinal products out of Schedule 1, will allow the evidence base on the therapeutic benefits associated with using this class of drugs to be improved through research, maximising benefits to patients.”
Given the particularly backward conservatism of UK politics, it is no surprise that the government is unmoved on recreational use and the right to grow. However, this was only Part 1 of the Cannabis Scheduling Review, and it recommends that the UK government should now carry out its own research to determine which kinds of medicinal cannabis are beneficial for different types of medical conditions.
The UKCSC will continue to make the right to grow a central demand of the legalisation movement.
England the most scientists come from there?“Cannabis has many active chemicals and only cannabis or derivatives produced for medical use can be assumed to have the correct concentrations and ratios. Using other forms, such as grown or street cannabis, as medicine for therapeutic benefit is potentially dangerous. The evidence that cannabis and some of its derivatives can be addictive and harmful has been known for some time and is not disputed by recent science, so I believe the reasons it is a controlled drug in the UK stand.
“Because different forms of grown cannabis have different concentrations and ratios of THC, grown or street cannabis cannot safely be substituted for medicinal cannabis.”
IMO the first underlined section above is a total bollocks. Just unadulterated BS.
As for the second underlined section, I will bet Dame Davies anything her little heart desires that in ANY location in the UK that she wishes to name that I will, within a given time period, find at least an order of magnitude more alcoholics (alcohol addicts) than MJ addicts.
Yeah?
“Cannabis has many active chemicals and only cannabis or derivatives produced for medical use can be assumed to have the correct concentrations and ratios. Using other forms, such as grown or street cannabis, as medicine for therapeutic benefit is potentially dangerous. The evidence that cannabis and some of its derivatives can be addictive and harmful has been known for some time and is not disputed by recent science, so I believe the reasons it is a controlled drug in the UK stand.
“Because different forms of grown cannabis have different concentrations and ratios of THC, grown or street cannabis cannot safely be substituted for medicinal cannabis.”
IMO the first underlined section above is a total bollocks. Just unadulterated BS.
As for the second underlined section, I will bet Dame Davies anything her little heart desires that in ANY location in the UK that she wishes to name that I will, within a given time period, find at least an order of magnitude more alcoholics (alcohol addicts) than MJ addicts.
Yeah?
British public backs legalization of cannabis so it can be sold like cigarettes and alcohol, poll reveals
51 per cent say it is time to treat the drug in the same way as other legal substances. A majority of the British public back the legalisation of cannabis so that it would be sold in shops like alcohol and tobacco, a poll has revealed.
There was also majority support for decriminalisation, something that would free up police time and resources to deal with serious crime. The exclusive BMG Research poll for The Independent comes days after cannabis oil was for the first time brought into the UK legally, to treat an epileptic boy.
But within hours of the landmark moment, a young girl was rushed into hospital and placed on life support while she awaited a licence to get the same oil.
More than 1,500 people were asked if they supported or opposed the proposal that “cannabis be legalised, so that it is sold legally within a government regulated market in the same way that alcohol and tobacco is”.
Overall, 22 per cent strongly backed the move, while 29 per cent somewhat supported it, bringing total support to 51 per cent. Some 19 per cent opposed the move strongly, and 16 per cent, somewhat, bringing the proportion of those against it to 35 per cent, while 14 per cent did not know.
The respondents were then asked: “To what extent would you support or oppose cannabis be decriminalised, so that it is still a controlled substance not available for sale on the market, but that it is not criminalised (i.e. no prosecution for possession)?”
Here support rose slightly, to 52 per cent overall – with 20 per cent strongly backing it and 32 per cent somewhat behind the idea. Some 17 per cent somewhat opposed the move, while 16 per cent strongly opposed it – total opposition of 33 per cent – and 16 per cent did not know.
High profile figures have recently backed legalisation, including former Conservative leader and foreign secretary William Hague, who said his party should be “bold” in embracing a “decisive change that would be economically and socially beneficial”.
Durham police chief Mike Barton agreed with Lord Hague that the current system is not working and that the drug should be legalised. He said: “The status quo is not tenable. It’s getting worse. Drugs are getting cheaper, stronger, more readily available and more dangerous.
“I have come reluctantly over the years to the conclusion that we need to regulate the market.”
Meanwhile, the charity Health Poverty Action recently estimated that legalising the drug and regulating its sale could bring in £3.5bn of tax revenue for the government every year, including extra money for the NHS.
However, a major research project that reviewed the combined results of a series of studies across Europe, recently backed previous evidence that there is a clear link between cannabis and mental health problems.
The combined results of seven studies, which looked at psychotic outcomes, found the odds of developing psychosis when a person had ever used cannabis in their life were increased by 41 per cent. The combined results of studies examining more frequent cannabis use showed an even greater chance of developing psychosis.
New home secretary Sajid Javid announced a review of the medicinal use of cannabis, after the mother of 12-year-old Billy Caldwell, who had cannabis oil to treat his epilepsy confiscated from her at Heathrow, demanded a change in the law.
Mr Javid told MPs: “It has become clear to me since becoming home secretary that the position we find ourselves in currently is not satisfactory. It is not satisfactory for the parent, it’s not satisfactory for the doctors and it’s not satisfactory for me.
“I’ve now come to the conclusion that it is time to review the scheduling of cannabis.”
The commission he established has since explored evidence of the medical benefits of cannabis, with government advisors set to recommend what products might be rescheduled. He underlined that there is no question of the government legalising cannabis for recreational use, with penalties for unauthorised supply and possession remaining in place.
Last week Hannah Deacon, a mother of another boy with epilepsy, was allowed to pass through London City Airport carrying a five-month supply of cannabis from Amsterdam. Licences for her son Alfie Dingley to be treated were granted by the Home Office on 19 June, after a long-running battle.
But Sophia Gibson, six, from Newtownards, County Down, was rushed to hospital and placed on life support on the same day as she awaits a licence. She suffers from a severe form of epilepsy known as Dravet syndrome. Her parents, Danielle and Darren, say the medication relieves their daughter’s condition.
Sponsored by |
---|